Neelakantan P - Search Results

1

A heptadeca amino acid peptide subunit of cathelicidin LL-37 has previously unreported antifungal activity.

Kalimuthu S, Pudipeddi A, Braś G, Tanner JA, Rapala-Kozik M, Leung YY, Neelakantan P. Kalimuthu S, et al. Among authors: neelakantan p. APMIS. 2023 Nov;131(11):584-600. doi: 10.1111/apm.13322. Epub 2023 May 7. APMIS. 2023. PMID: 37150907

2

Facial protection in the era of COVID-19: A narrative review.

Li DTS, Samaranayake LP, Leung YY, Neelakantan P. Li DTS, et al. Among authors: neelakantan p. Oral Dis. 2021 Apr;27 Suppl 3(Suppl 3):665-673. doi: 10.1111/odi.13460. Epub 2020 Jun 29. Oral Dis. 2021. PMID: 32506757 Free PMC article. Review.

3

Guardian genes ensuring subsistence of oral Streptococcus mutans.

Shanmugam K, Sarveswari HB, Udayashankar A, Swamy SS, Pudipeddi A, Shanmugam T, Solomon AP, Neelakantan P. Shanmugam K, et al. Among authors: neelakantan p. Crit Rev Microbiol. 2020 Aug;46(4):475-491. doi: 10.1080/1040841X.2020.1796579. Epub 2020 Jul 28. Crit Rev Microbiol. 2020. PMID: 32720594 Review.

4

Exploration of Anti-infectives From Mangrove-Derived Micromonospora sp. RMA46 to Combat Vibrio cholerae Pathogenesis.

Sarveswari HB, Kalimuthu S, Shanmugam K, Neelakantan P, Solomon AP. Sarveswari HB, et al. Among authors: neelakantan p. Front Microbiol. 2020 Jul 10;11:1393. doi: 10.3389/fmicb.2020.01393. eCollection 2020. Front Microbiol. 2020. PMID: 32765430 Free PMC article.

5

A Novel Small Molecule, 1,3-di-m-tolyl-urea, Inhibits and Disrupts Multispecies Oral Biofilms.

Kalimuthu S, Cheung BPK, Yau JYY, Shanmugam K, Solomon AP, Neelakantan P. Kalimuthu S, et al. Among authors: neelakantan p. Microorganisms. 2020 Aug 20;8(9):1261. doi: 10.3390/microorganisms8091261. Microorganisms. 2020. PMID: 32825310 Free PMC article.

6

Biofilm inhibition in oral pathogens by nanodiamonds.

Zhang T , Kalimuthu S , Rajasekar V , Xu F , Yiu YC , Hui TKC , Neelakantan P , Chu Z . Zhang T , et al. Among authors: neelakantan p. Biomater Sci. 2021 Aug 7;9(15):5127-5135. doi: 10.1039/d1bm00608h. Epub 2021 May 17. Biomater Sci. 2021. PMID: 33997876

7

Small molecule based anti-virulence approaches against Candida albicans infections.

Kalimuthu S, Alshanta OA, Krishnamoorthy AL, Pudipeddi A, Solomon AP, McLean W, Leung YY, Ramage G, Neelakantan P. Kalimuthu S, et al. Among authors: neelakantan p. Crit Rev Microbiol. 2022 Nov;48(6):743-769. doi: 10.1080/1040841X.2021.2025337. Epub 2022 Mar 2. Crit Rev Microbiol. 2022. PMID: 35232325 Free article. Review.

8

Trans-Cinnamaldehyde Eluting Porous Silicon Microparticles Mitigate Cariogenic Biofilms.

Jailani A, Kalimuthu S, Rajasekar V, Ghosh S, Collart-Dutilleul PY, Fatima N, Koo H, Solomon AP, Cuisinier F, Neelakantan P. Jailani A, et al. Among authors: neelakantan p. Pharmaceutics. 2022 Jul 7;14(7):1428. doi: 10.3390/pharmaceutics14071428. Pharmaceutics. 2022. PMID: 35890323 Free PMC article.

9

Design, dynamic docking, synthesis, and in vitro validation of a novel DNA gyrase B inhibitor.

Pudipeddi A, Vasudevan S, Shanmugam K, Mohan S S, Vairaprakash P, Neelakantan P, Balraj AS, Solomon AP. Pudipeddi A, et al. Among authors: neelakantan p. J Biomol Struct Dyn. 2023 Aug-Sep;41(13):6345-6358. doi: 10.1080/07391102.2022.2107073. Epub 2022 Aug 4. J Biomol Struct Dyn. 2023. PMID: 35924774

10

Trans-cinnamaldehyde-Biosurfactant Complex as a Potent Agent against Enterococcus faecalis Biofilms.

Hu M, Kalimuthu S, Zhang C, Ali IAA, Neelakantan P. Hu M, et al. Among authors: neelakantan p. Pharmaceutics. 2022 Oct 31;14(11):2355. doi: 10.3390/pharmaceutics14112355. Pharmaceutics. 2022. PMID: 36365173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page